News
TNDM
--
0.00%
--
Is TNDM Stock A Buy or Sell?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money invest...
Insider Monkey · 16h ago
BRIEF-Cequr Announces Close Of An Oversubscribed $115 Million Equity Financing
reuters.com · 04/13 12:34
CeQur Raises $115 Million Series C5 Financing to Support Commercialization and Scale-Up of Automated Manufacturing for CeQur Simplicity Wearable Insulin-Delivery Device
CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, today announced the close of an oversubscribed $115 million equity financing. The company will use the funds to advan...
Business Wire · 04/13 12:00
Press Release: Tandem Diabetes Care to Announce First Quarter 2021 Financial Results on May 5, 2021
Dow Jones · 04/06 20:06
Analysts Conflicted on These Healthcare Names: Tandem Diabetes Care (TNDM), Theravance Biopharma (TBPH) and TRACON Pharmaceuticals (TCON)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tandem Diabetes Care (TNDM), Theravance Biopharma (TBPH) and TRACON
SmarterAnalyst · 04/01 12:25
DJ Tandem Diabetes Care Price Target Cut to $95.00/Share From $115.00 by SVB Leerink
Dow Jones · 04/01 10:45
DJ Tandem Diabetes Care Is Maintained at Market Perform by SVB Leerink
Dow Jones · 04/01 10:45
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Cormedix (CRMD)
SmarterAnalyst · 03/31 09:55
Tandem Diabetes Care, Inc. (TNDM) Down 13.2% Since Last Earnings Report: Can It Rebound?
Zacks.com · 03/26 22:03
Here's Why You Should Hold on to Tandem Diabetes (TNDM) Stock
Zacks.com · 03/23 22:30
DJ Insulet Stock Rises as It Joins the Automated Insulin Device Competition -- Barrons.com
Dow Jones · 03/22 23:14
4 Stocks in Focus as Diabetes Sector Grows Amid Pandemic
Zacks.com · 03/19 12:38
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Synlogic (SYBX) and Intersect ENT (XENT)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Tandem Diabetes Care (TNDM), Synlogic (SYBX) and
SmarterAnalyst · 03/18 11:11
Heres Why Tandem Diabetes Care (TNDM) Became Alger Small Caps Top Detractor
Alger, an investment management firm, published its ‘Alger Small Cap Focus Fund’ fourth quarter 2020 investor letter – a copy of which can be downloaded here. In the letter, the fund highlighted their largest portfolio sector weightings, which is in the He...
Insider Monkey · 03/15 17:43
Tandem (TNDM) Grows on Abbott, Dexcom Pacts Amid COVID-19 Woes
Zacks.com · 03/12 15:01
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations
Business Wire · 03/03 21:05
Tandem Diabetes Care (NASDAQ:TNDM) Has Debt But No Earnings; Should You Worry?
Simply Wall St. · 03/02 13:01
Is Tandem Diabetes Care (TNDM) Stock a Buy For 2021?
Insider Monkey · 03/01 16:29
Webull provides a variety of real-time TNDM stock news. You can receive the latest news about Tandem Diabetes through multiple platforms. This information may help you make smarter investment decisions.
About TNDM
Tandem Diabetes Care, Inc. is a medical device company engaged in the designing, developing and commercialization of products for people with insulin-dependent diabetes. The Company’s manufacturing, sales and support activities principally focus on its flagship pump platform, the t:slim X2 Insulin Delivery System (t:slim X2), and its product offerings. The t:slim X2 is based on its technology platform and is capable of remote feature updates and is designed to display continuous glucose monitoring (CGM) sensor information directly on the pump home screen. Its products also include Basal-IQ technology and Control-IQ technology. The Basal-IQ technology is a predictive low glucose suspend feature that is designed to temporarily suspend insulin delivery to help reduce the frequency and duration of hypoglycemic events. The Control-IQ technology is a hybrid-closed loop feature, designed to help increase a user's time in targeted glycemic range.